Single User License
INR 101895
Site License
INR 203790
Corporate User License
INR 305685

Service Tax Additional

select a format
Price

Single User License
USD 1500
Site License
USD 3000
Corporate User License
USD 4500

Alternatively

Request a quote
Request a Customized research
Request for Sample Report





Recent Viewed Reports


Why Ken Reasearch?


Testimonials

While we still are studying and analysing your reports about Vietnam & Thailand, we would like to convey to your research team that they have done a very good job in compiling so much of information together. We hope to see more of such well researched reports. All the best & keep it up. ... "Prashant Bhagwat,General Manager, Mahindra"

We would like to appreciate Ken Research for their great efforts and wonderful support in providing the Market Intelligence Report for ITPC. The information, statistics and research are well understandable and very clear to the point. We are happy with Ken research for their good client service, on-time delivery of the report and as said the report itself. Thank you Ken research for bringing the valuable output for us. We would be looking forward to have more research with you in the near future. Wish you a success in your business!... "Jestin Mathew, Indonesian Trade Promotion Center"

The Report was very interesting and useful for me... "Marketing Manager, Western Union Business Solutions"

Ken Research completed the report successfully with tough deadline and large requirement. Really appreciate it... "Sales Manager, Largest India Aesthetic Laser Manufacturer"

We found the report really useful in understanding the complex Indian market and it provided lots of high quality insights. On the basis of this we commissioned Ken to produce a bespoke follow up to answer some specific questions about our market. This is now being used to help develop our marketing and sales strategy. We were very pleased with the comprehensive coverage, detail provided and actionable insights.... "Owner, Therefore Consulting UK"


Sunesis Pharmaceuticals, Inc.-Product Pipeline Review-2015

Sunesis Pharmaceuticals, Inc.-Product Pipeline Review-2015


  Request for Sample Report

Executive Summary

Sunesis Pharmaceuticals, Inc.-Product Pipeline Review-2015

Summary

Global Markets Direct's, 'Sunesis Pharmaceuticals, Inc.-Product Pipeline Review-2015', provides an overview of the Sunesis Pharmaceuticals, Inc.'s pharmaceutical research and development focus.

This report provides comprehensive information on the current therapeutic developmental pipeline of Sunesis Pharmaceuticals, Inc.'s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.

Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

The report provides brief overview of Sunesis Pharmaceuticals, Inc. including business description, key information and facts, and its locations and subsidiaries

The report reviews current pipeline of Sunesis Pharmaceuticals, Inc.'s human therapeutic division and enlists all their major and minor projects

The report features product description and descriptive mechanism of action for key pipeline products along with the product's developmental history and major milestones

Special feature on out-licensed and partnered product portfolio

The report summarizes all the dormant and discontinued pipeline projects

Latest company statement

Latest news and deals relating to the Sunesis Pharmaceuticals, Inc.'s pipeline products

Reasons To Buy

Evaluate Sunesis Pharmaceuticals, Inc.'s strategic position with total access to detailed information on its product pipeline

Assess the growth potential of Sunesis Pharmaceuticals, Inc. in its therapy areas of focus

Identify new drug targets and therapeutic classes in the Sunesis Pharmaceuticals, Inc.'s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas

Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps

Develop strategic initiatives by understanding the focus areas of Sunesis Pharmaceuticals, Inc. and exploit collaboration and partnership opportunities

Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage

Plan mergers and acquisitions effectively by identifying the most promising pipeline of Sunesis Pharmaceuticals, Inc.

Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope

Explore the dormant and discontinued projects of Sunesis Pharmaceuticals, Inc. and identify potential opportunities in those areas

Avoid Intellectual Property Rights related issues

Table of Contents

Table of Contents 2

List of Tables 4

List of Figures 4

Sunesis Pharmaceuticals, Inc. Snapshot 5

Sunesis Pharmaceuticals, Inc. Overview 5

Key Information 5

Key Facts 5

Sunesis Pharmaceuticals, Inc.-Research and Development Overview 6

Key Therapeutic Areas 6

Sunesis Pharmaceuticals, Inc.-Pipeline Review 9

Pipeline Products by Stage of Development 9

Pipeline Products-Monotherapy 10

Pipeline Products-Out-Licensed Products 11

Out-Licensed Products/Combination Treatment Modalities 12

Sunesis Pharmaceuticals, Inc.-Pipeline Products Glance 13

Sunesis Pharmaceuticals, Inc.-Late Stage Pipeline Products 13

Phase III Products/Combination Treatment Modalities 13

Sunesis Pharmaceuticals, Inc.-Clinical Stage Pipeline Products 14

Phase II Products/Combination Treatment Modalities 14

Sunesis Pharmaceuticals, Inc.-Early Stage Pipeline Products 15

Preclinical Products/Combination Treatment Modalities 15

Sunesis Pharmaceuticals, Inc.-Drug Profiles 16

vosaroxin 16

Product Description 16

Mechanism of Action 16

R&D Progress 16

SNS-062 18

Product Description 18

Mechanism of Action 18

R&D Progress 18

SNS-229 19

Product Description 19

Mechanism of Action 19

R&D Progress 19

SNS-391 20

Product Description 20

Mechanism of Action 20

R&D Progress 20

SNS-510 21

Product Description 21

Mechanism of Action 21

R&D Progress 21

Sunesis Pharmaceuticals, Inc.-Pipeline Analysis 22

Sunesis Pharmaceuticals, Inc.-Pipeline Products by Target 22

Sunesis Pharmaceuticals, Inc.-Pipeline Products by Route of Administration 23

Sunesis Pharmaceuticals, Inc.-Pipeline Products by Molecule Type 24

Sunesis Pharmaceuticals, Inc.-Pipeline Products by Mechanism of Action 25

Sunesis Pharmaceuticals, Inc.-Recent Pipeline Updates 26

Sunesis Pharmaceuticals, Inc.-Dormant Projects 32

Sunesis Pharmaceuticals, Inc.-Discontinued Pipeline Products 33

Discontinued Pipeline Product Profiles 33

SNS-032 33

Sunesis Pharmaceuticals, Inc.-Company Statement 34

Sunesis Pharmaceuticals, Inc.-Locations And Subsidiaries 38

Head Office 38

Other Locations & Subsidiaries 38

Appendix 39

Methodology 39

Coverage 39

Secondary Research 39

Primary Research 39

Expert Panel Validation 39

Contact Us 39

Disclaimer 40

List of Tables

Sunesis Pharmaceuticals, Inc., Key Information 5

Sunesis Pharmaceuticals, Inc., Key Facts 5

Sunesis Pharmaceuticals, Inc.-Pipeline by Indication, 2015 8

Sunesis Pharmaceuticals, Inc.-Pipeline by Stage of Development, 2015 9

Sunesis Pharmaceuticals, Inc.-Monotherapy Products in Pipeline, 2015 10

Sunesis Pharmaceuticals, Inc.-Out-Licensed Products in Pipeline, 2015 11

Sunesis Pharmaceuticals, Inc.-Out-Licensed Products/ Combination Treatment Modalities, 2015 12

Sunesis Pharmaceuticals, Inc.-Phase III, 2015 13

Sunesis Pharmaceuticals, Inc.-Phase II, 2015 14

Sunesis Pharmaceuticals, Inc.-Preclinical, 2015 15

Sunesis Pharmaceuticals, Inc.-Pipeline by Target, 2015 22

Sunesis Pharmaceuticals, Inc.-Pipeline by Route of Administration, 2015 23

Sunesis Pharmaceuticals, Inc.-Pipeline by Molecule Type, 2015 24

Sunesis Pharmaceuticals, Inc.-Pipeline Products by Mechanism of Action, 2015 25

Sunesis Pharmaceuticals, Inc.-Recent Pipeline Updates, 2015 26

Sunesis Pharmaceuticals, Inc.-Dormant Developmental Projects,2015 32

Sunesis Pharmaceuticals, Inc.-Discontinued Pipeline Products, 2015 33

Sunesis Pharmaceuticals, Inc., Subsidiaries 38

List of Figures

Sunesis Pharmaceuticals, Inc.-Pipeline by Top 10 Indication, 2015 7

Sunesis Pharmaceuticals, Inc.-Pipeline by Stage of Development, 2015 9

Sunesis Pharmaceuticals, Inc.-Monotherapy Products in Pipeline, 2015 10

Sunesis Pharmaceuticals, Inc.-Out-Licensed Products in Pipeline, 2015 11

Sunesis Pharmaceuticals, Inc.-Pipeline by Top 10 Target, 2015 22

Sunesis Pharmaceuticals, Inc.-Pipeline by Top 10 Route of Administration, 2015 23

Sunesis Pharmaceuticals, Inc.-Pipeline by Top 10 Molecule Type, 2015 24

Sunesis Pharmaceuticals, Inc.-Pipeline Products by Top 10 Mechanism of Action, 2015 25

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to query [@] kenresearch.com
 

Current R&D Portfolio of Sunesis Pharmaceuticals, Inc.; Sunesis Pharmaceuticals, Inc. - Key Therapeutics; Sunesis Pharmaceuticals, Inc. - Pipeline Overview and Promising Molecules; Sunesis Pharmaceuticals, Inc. - News; Sunesis Pharmaceuticals, Inc. - Latest Updates; Sunesis Pharmaceuticals, Inc. - Pipeline; Sunesis Pharmaceuticals, Inc. - Discontinued/Dormant Projects


Related Products in vertical
Other reports by publisher
Ken Research Pvt. Ltd. 27A, Tower B-2, Spaze I Tech Business Park, Sohna Road, sector 49
     Gurgaon, Haryana - 122001, India
+91 1244230204

download

Company Brochure

Engage with Us

query [@] kenresearch.com